Cargando…
Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?
BACKGROUND: Mefloquine is a clinically important antimalaria drug, which is often not well tolerated. We critically reviewed 516 published case reports of mefloquine adverse effects, to clarify the phenomenology of the harms associated with mefloquine, and to make recommendations for safer prescribi...
Autores principales: | Croft, Ashley M, Herxheimer, Andrew |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC101408/ https://www.ncbi.nlm.nih.gov/pubmed/11914150 http://dx.doi.org/10.1186/1471-2458-2-6 |
Ejemplares similares
-
Ferrocene-Based Compounds with Antimalaria/Anticancer Activity
por: Peter, Sijongesonke, et al.
Publicado: (2019) -
Towards the next generation of antimalaria combination therapies
por: Möhrle, Jörg J
Publicado: (2021) -
Plants as Sources of Natural and Recombinant Antimalaria Agents
por: Habibi, Peyman, et al.
Publicado: (2022) -
Mechanistic Understanding of the Olfactory Neuroepithelium Involvement Leading to Short-Term Anosmia in COVID-19 Using the Adverse Outcome Pathway Framework
por: Shahbaz, Muhammad Ali, et al.
Publicado: (2022) -
Activities of Indian Antimalaria Units in World War II
por: Nair, C. P.
Publicado: (1949)